Principal Financial Group Inc Denali Therapeutics Inc. Transaction History
Principal Financial Group Inc
- $160 Billion
- Q2 2024
A detailed history of Principal Financial Group Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,088,537 shares of DNLI stock, worth $31.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,088,537
Previous 1,122,536
3.03%
Holding current value
$31.7 Million
Previous $23 Million
9.73%
% of portfolio
0.02%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding DNLI
# of Institutions
214Shares Held
121MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$401 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$330 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$286 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$208 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.91B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...